Immune system and hepatitis B virus infection (Q36388375)

13 August 2017

1 reference

title

Immune system and hepatitis B virus infection (English)

1 reference

13 August 2017

1 reference

1 reference

Chee-Kin Hui

1

1 reference

PubMed ID

16461223

13 August 2017

George K K Lau

series ordinal

2

1 reference

13 August 2017

1 December 2005

1 reference

Journal of Clinical Virology

13 August 2017

1 reference

13 August 2017

34 Suppl 1

1 reference

13 August 2017

S44-8

1 reference

Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection

13 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980009-5

7 January 2021

Protection or damage: a dual role for the virus-specific cytotoxic T lymphocyte response in hepatitis B and C infection?

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980009-5

7 January 2021

Human histocompatibility leukocyte antigen-binding supermotifs predict broadly cross-reactive cytotoxic T lymphocyte responses in patients with acute hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980009-5

7 January 2021

Initial and innate responses to viral infections--pattern setting in immunity or disease

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980009-5

7 January 2021

Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980009-5

7 January 2021

Transient restoration of anti-viral T cell responses induced by lamivudine therapy in chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980009-5

7 January 2021

Hepatitis B virus mutants.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980009-5

7 January 2021

From hepatitis to hepatoma: lessons from type B viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980009-5

7 January 2021

Cytotoxic T cells and viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980009-5

7 January 2021

Hepatitis B virus immunopathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980009-5

7 January 2021

Temporal pathogenesis of experimental neonatal woodchuck hepatitis virus infection: increased initial viral load and decreased severity of acute hepatitis during the development of chronic viral infection

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980009-5

7 January 2021

Mutations in core nucleotide sequence of hepatitis B virus correlate with fulminant and severe hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980009-5

7 January 2021

Identification of immunodominant T cell epitopes of the hepatitis B virus nucleocapsid antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980009-5

7 January 2021

Cytokine-induced viral purging--role in viral pathogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980009-5

7 January 2021

Noncytolytic control of viral infections by the innate and adaptive immune response

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980009-5

7 January 2021

Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980009-5

7 January 2021

Viral Clearance Without Destruction of Infected Cells During Acute HBV Infection

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980009-5

7 January 2021

Apoptosis and regeneration of hepatocytes during recovery from transient hepadnavirus infections

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980009-5

7 January 2021

The interferon in TLR signaling: more than just antiviral

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980009-5

7 January 2021

Clinical relevance of hepatitis B viral mutations

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980009-5

7 January 2021

Evidence for a deficiency of interferon production in patients with chronic hepatitis B virus infection acquired in adult life

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980009-5

7 January 2021

Natural killer T cell activation inhibits hepatitis B virus replication in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980009-5

7 January 2021

Cutting edge: Inhibition of hepatitis B virus replication by activated NK T cells does not require inflammatory cell recruitment to the liver

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980009-5

7 January 2021

Global programme for control of hepatitis B infection

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980009-5

7 January 2021

Clearance of hepatitis B surface antigen after bone marrow transplantation: Role of adoptive immunity transfer

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980009-5

7 January 2021

Clearance of persistent hepatitis B virus infection in Chinese bone marrow transplant recipients whose donors were anti-hepatitis B core- and anti-hepatitis B surface antibody-positive

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980009-5

7 January 2021

Resolution of chronic hepatitis B and anti-HBs seroconversion in humans by adoptive transfer of immunity to hepatitis B core antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980009-5

7 January 2021

Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980009-5

7 January 2021

A prospective study characterizing full-length hepatitis B virus genomes during acute exacerbation

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980009-5

7 January 2021

Origin of serum hepatitis B virus in acute exacerbation: comparison with HBV in the liver and from other exacerbation.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980009-5

7 January 2021

Evolution of hepatitis B virus polymerase gene mutations in hepatitis B e antigen-negative patients receiving lamivudine therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980009-5

7 January 2021

Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980009-5

7 January 2021

The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980009-5

7 January 2021

Relative sensitivity of hepatitis B virus and other hepatotropic viruses to the antiviral effects of cytokines.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980009-5

7 January 2021

Deficiencies in the acute-phase cell-mediated immune response to viral antigens are associated with development of chronic woodchuck hepatitis virus infection following neonatal inoculation

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980009-5

7 January 2021

Significance of pre-S region-defective hepatitis B virus that emerged during exacerbation of chronic type B hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980009-5

7 January 2021

Pathogenesis of experimental neonatal woodchuck hepatitis virus infection: chronicity as an outcome of infection is associated with a diminished acute hepatitis that is temporally deficient for the expression of interferon gamma and tumor necrosis f

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980009-5

7 January 2021

Cytokine-sensitive replication of hepatitis B virus in immortalized mouse hepatocyte cultures

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980009-5

7 January 2021

Acute flares in chronic hepatitis B: the natural and unnatural history of an immunologically mediated liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980009-5

7 January 2021

The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980009-5

7 January 2021

Antiviral actions of interferons

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980009-5

7 January 2021

Hepatitis B virus biology

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980009-5

7 January 2021

A longitudinal analysis of cytotoxic T lymphocyte precursor frequencies to the hepatitis B virus in chronically infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980009-5

7 January 2021

Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. Implications for hepatitis B e antigen seroconversion

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980009-5

7 January 2021

Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980009-5

7 January 2021

Intrahepatic induction of alpha/beta interferon eliminates viral RNA-containing capsids in hepatitis B virus transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980009-5

7 January 2021

10.1016/S1386-6532(05)80009-5

Identifiers

DOI

1 reference

13 August 2017

1 reference

PubMed ID

16461223